BPC-157 vs TB-500: A Research Comparison
How two of the most-studied research peptides differ — molecular background and why labs source each.
BPC-157 and TB-500 are two of the most frequently sourced peptides in Canadian research labs, and they are often discussed together. This comparison is written for researchers evaluating reference materials — it makes no health claims and provides no dosing guidance.
BPC-157 at a glance
BPC-157 is a synthetic peptide fragment studied in the scientific literature in models of tissue and connective-tissue research. It is supplied lyophilized as a reference compound for in-vitro laboratory work only. See the BPC-157 product page.
TB-500 at a glance
TB-500 is a synthetic version of a fragment of thymosin beta-4, a naturally occurring peptide. It is studied in a research context distinct from BPC-157 and is likewise supplied strictly as a reference material. See the TB-500 product page.
How researchers choose between them
Because the two peptides have different molecular origins and are examined in different experimental contexts, labs typically select based on the specific research model rather than treating them as interchangeable. Some protocols in the literature reference them together; that does not imply any equivalence or combined effect, and Québectides makes no such claims.
Sourcing and handling
Both are supplied lyophilized and ship from Québec, Canada-wide. Store and reconstitute according to good laboratory practice — see Reconstitution & Storage. For selection criteria beyond the compound itself, see Buying Research Peptides in Canada.
For research and laboratory use only. Not for human consumption, diagnosis, treatment, or cure of any condition. This article is general reference information and not medical advice.